In recent years, the health sector has witnessed a surge in startup activity across areas like digital health, herbal medicine, medical devices, and smart health services.
The herbal medicine industry has seen significant global growth in recent years. International brands such as Himalaya, Weleda, and Gedeon Richter have successfully combined traditional herbal knowledge with modern scientific innovation and strict international standards to secure leading positions in global markets.
In today's competitive business world, many companies are turning to Case Studies and Benchmarks to minimize risks and enhance efficiency.
In recent years, the importance of Intellectual Property Registration in the pharmaceutical industry has significantly increased. With the rapid growth of technology and easier access to information, the risk of formula theft and duplication is higher than ever.
Padideh Giah Technology Development Center has launched the upgrade and modernization of its herbal drug production lines using the most advanced specialized equipment.
Padideh Giah has officially introduced specialized services for the design and construction of clean rooms dedicated to herbal product processing. This new initiative aims to enhance the quality and safety of herbal medicines and increase the competitiveness of domestic products in international markets.
With the growing global demand for herbal medicines, complying with GMP, HACCP, and ISO standards in medicinal plant processing has become a critical necessity.
As the global demand for herbal medicine continues to rise, ensuring high-quality and contamination-free production has become essential
In recent years, the growing public interest in health and wellness has led to a surge in demand for herbal medicines. As this demand increases, so does the need for advanced and hygienic production infrastructures. One of the most critical components in the safe and standardized production of herbal products is the Cleanroom.
As global demand for herbal medicines continues to rise, ensuring compliance with international production standards has become more important than ever. In response, a growing number of companies in the herbal pharmaceutical sector are investing in cleanroom (controlled environment) infrastructure to manufacture high-quality, GMP-compliant herbal products.
With the global rise in demand for herbal medicines and health-oriented products, many research teams and innovators in Iran and across the region are turning their scientific breakthroughs into commercial ventures. Yet, one of the main challenges facing pharmaceutical startups is the lack of a clear and sustainable business model.
In today’s competitive health innovation landscape, many startups in the field of herbal medicine and natural health products face challenges such as fundraising, obtaining regulatory approvals, and market entry. One of the most essential tools to overcome these barriers is crafting a health-focused business plan — a strategic document that guides a startup from concept to commercialization.
In today’s innovation-driven health industry, strategic networking with business incubators and science and technology parks is emerging as a crucial success factor for startups active in the field of herbal medicine and natural health products.
With the growing demand for plant-based pharmaceuticals globally, universities and academic institutions are playing an increasingly vital role in developing, innovating, and commercializing herbal medicine products.
As part of its ongoing efforts to strengthen media relations and showcase its strategic capabilities at the national level, today, Monday, 12 Khordad 1404 (June 2, 2025), Mr. Ali Torani, the esteemed CEO of Padideh Giah Technology Development Center, appeared in two major national media programs to present the center's vision, achievements, and future goals.
In recent years, the advancement of health-oriented technologies and the commercialization of herbal and pharmaceutical innovations have relied heavily on a structured innovation ecosystem. In Iran, this ecosystem includes essential stakeholders such as the Iranian Food and Drug Administration (IFDA), public innovation funding institutions, and health-focused venture capital investors. In this article, we introduce these key players and their roles in enabling innovation.
Padideh Giah has officially announced the establishment of a specialized Health Innovation Ecosystem aimed at accelerating startups and facilitating technology commercialization in the field of herbal medicine and health technologies.
As global demand for herbal medicines and natural products continues to rise, one of the most critical factors in successful international trade is standardized and export-ready packaging.
In a move to boost non-oil exports and support health-based innovation, Iran is streamlining the export license process for herbal medicines. This initiative involves collaboration between the Iran Food and Drug Administration (IFDA), Iran Customs, and specialized pharmaceutical accelerators.
The increasing global demand for natural and low-side-effect remedies has positioned Iran’s neighboring countries as promising destinations for herbal medicine exports. Over the past few years, Iran’s exports of herbal products to markets such as Iraq, Afghanistan, CIS countries, India, and China have shown remarkable growth.
Recent studies reveal that the global herbal medicine market is experiencing a compound annual growth rate (CAGR) of over 8%, projected to surpass USD 415 billion by 2030. Despite its rich biodiversity — with over 2,300 species of medicinal plants — Iran currently holds less than 0.5% of the global herbal export market.
According to the latest reports from the World Health Organization (WHO) and international market research institutes, the global herbal medicine market is projected to surpass $500 billion by 2030. This rapid growth has caught the attention of countries with strong biodiversity and traditional medicine capabilities.
In recent years, laboratory validation has emerged as a critical factor in obtaining licenses and ensuring the quality of pharmaceutical products, particularly in the herbal medicine sector. Experts believe that robust validation processes are essential for achieving regulatory approvals and entering international markets.
Padideh Giah, a leading accelerator in the field of herbal and botanical medicines, has officially launched a suite of formulation consulting and stability testing services aimed at supporting startups, pharmaceutical companies, and researchers in the natural health industry.
Padideh Giah Accelerator has launched a new initiative aimed at facilitating the commercialization of herbal medicines through the setup and operation of pilot-scale production lines. This service is designed to help startups, researchers, and herbal product manufacturers validate and optimize their production processes before investing in full-scale manufacturing.
In the process of herbal drug innovation, access to advanced laboratory equipment is a major enabler for startups and researchers. Padideh Giah Accelerator has equipped its labs with specialized devices that support every stage of herbal product development—from extraction and formulation to quality control and regulatory documentation.
Padideh Giah, a leading accelerator in herbal biotechnology, is taking a bold step toward integrating Artificial Intelligence (AI) into the development of plant-based recombinant drugs.
With the expansion of technological infrastructure and specialized laboratories, health-focused accelerators are playing a key role in supporting pharmaceutical startups. This trend is accelerating the commercialization of herbal products and paving the way for sustainable growth in the health sector.
With the global herbal medicine market growing rapidly, ensuring product quality, efficacy, and shelf stability has become more important than ever. One major area of focus is the development of stable formulations that can preserve the active botanical ingredients under various environmental conditions.
As the herbal medicine industry continues to grow, regulatory bodies are imposing stricter standards on documentation. According to Padideh Giah Accelerator, many innovative products fail to receive the necessary licenses not because of poor quality, but due to incomplete or non-standard documentation.
Amid growing global demand for plant-based therapeutics, investment in preclinical and clinical phases of herbal drug development has seen a sharp rise. According to a recent report by the World Health
The process starts with identifying bioactive compounds and continues through formulation, safety testing, pilot production, and—if needed—clinical trials. Obtaining regulatory approvals and scaling production under GMP are crucial steps for market readiness.
Herbal Drug Development Roadmap in the Medicinal Plant Industry Published by Padideh Giah
In recent years, the path from herbal research to pharmaceutical-grade products has become more streamlined, thanks to the support of specialized health accelerators. Researchers and health-focused entrepreneurs are increasingly transforming herbal formulations into market-ready products through a structured commercialization process.
According to recent reports, the global herbal medicine market is expected to exceed $500 billion by 2030. The rapid growth of startups and the entry of major pharmaceutical companies into the natural health space signal a paradigm shift.
Specialized pharmaceutical accelerators continue to play a pivotal role in health innovation. According to recent reports, JLABS (run by Johnson & Johnson), IndieBio, StartUp Health, and BioMotiv are among the most successful accelerators in the world.
As global interest in herbal medicine continues to grow, the path for launching innovative startups in the field of natural health has become more accessible. In response, Padideh Giah Accelerator has published a new educational article titled “How to Launch a Herbal Pharmaceutical Startup” to support students, entrepreneurs, and investors in the health industry.
As health-oriented startups continue to grow, the distinction between general accelerators and specialized health accelerators is becoming increasingly significant. General accelerators support innovation across various industries, whereas specialized accelerators in the health sector offer tailored mentorship, infrastructure, and resources designed specifically for healthcare startups.
With the rapid global growth of the herbal medicine market, startup accelerators are playing an increasingly vital role in supporting innovation and commercializing ideas in this field. Specialized accelerators provide startups with access to research infrastructure, expert mentoring, regulatory guidance, and training aligned with international standards—paving the way for scalable and market-ready herbal products.
With the growing demand in the global herbal medicine market, the need for innovative startups in this field is more urgent than ever. Padideh Giah Accelerator has launched a dedicated platform to support and empower entrepreneurs working in the medicinal plants and herbal products sector. By offering specialized mentorship, educational workshops, networking opportunities, co-working spaces, and investor connections, Padideh Giah is helping transform raw ideas into market-ready herbal solutions. The accelerator aims to build a dynamic ecosystem where science, innovation, and nature converge to create sustainable growth and global competitiveness for herbal-based ventures.
In an innovative move that marks a turning point in the herbal medicine industry, Iranian researchers and startups are now leveraging Artificial Intelligence (AI) to optimize the cultivation and processing of medicinal plants. This technology allows for more accurate identification of plant species, prediction of their active compounds, and enhanced extraction techniques, significantly improving the efficiency and quality of herbal products. Accelerators such as Padideh Giah are playing a crucial role in supporting these AI-powered startups. By providing technical resources, mentorship, and access to research infrastructure, they are enabling a new generation of health-tech innovators to bridge the gap between traditional knowledge and cutting-edge technology. Experts believe that this digital transformation will not only boost the competitiveness of Iran’s herbal industry in global markets but also pave the way for sustainable, nature-friendly medical solutions.
In recent months, several domestic companies and producers have begun utilizing the Internet of Things (IoT) in the cultivation and production of medicinal plants. These systems, through the use of environmental sensors, collect real-time data on temperature, humidity, light, and CO₂ levels, enabling farmers to make quick and accurate decisions. One executive from a company active in this field stated: “By adopting IoT, we’ve been able to reduce water consumption by up to 30% and improve the quality of active compounds in our plants.” It is predicted that within the next five years, over 60% of large-scale medicinal plant farms in Iran will be equipped with smart systems.
Laboratory Infrastructure and Formulation Services Available to Idea Owners Without the Need for Independent Space Padideh Giah Accelerator has announced that idea owners in the fields of herbal medicines, natural supplements, and cosmetic products can now take advantage of the center’s full laboratory infrastructure and custom formulation services, without needing to equip their own laboratory or set up a research space. From Idea to Product, Without Worrying About Infrastructure In this program, individuals or teams with a raw idea or initial formulation, but lacking workshop or laboratory space, can benefit from Padideh Giah's facilities for formulation development, prototype production, specialized testing, and even the preparation of documentation for registration and approvals. "At Padideh Giah, our focus is on making the commercialization process of ideas easier and faster for startups and researchers. Our laboratory infrastructure is not only technically equipped but is also supported by a dedicated team familiar with the product development processes in the field of medicinal plants." Available Services for Teams and Individuals: Scientific and Custom Product Formulation Raw Material Analysis and Quality Control Stability, Absorption, and Efficacy Testing Prototype Production for Market Testing or Investor Presentation Scientific Support for Registration and Licensing Processes Enter the Operational Phase Without Heavy Investment By providing these facilities, Padideh Giah has created a golden opportunity for those with new ideas who have been unable to start their journey due to lack of technical resources.
The latest report published by the Central Bank includes new facilities to support new businesses and startups. These facilities, which include low-interest loans with long-term repayment, provide a good opportunity for small business owners to secure the initial capital or liquidity they need.
Padeideh Giah, a leading company in the field of herbal medicine and traditional remedies, has announced the launch of its specialized Know-how Valuation Services for industry professionals and investors. Technical know-how is considered one of the most important intangible assets in the pharmaceutical sector—particularly in the herbal medicine industry—playing a vital role in economic development, product commercialization, and attracting investors. In response to this need, Padeideh Giah, leveraging a team of experts and adhering to international standards, now offers in-depth analysis, documentation, and real valuation of proprietary know-how and formulations. These services include the preparation of official valuation reports suitable for submission to banks, stock market authorities, and investment institutions, along with legal consulting for the registration and transfer of technical know-how.
As the traditional medicine and herbal medicine industry in the country is facing increasing popularity, the need to accelerate production infrastructure, including the construction of pharmaceutical factories, is felt more than ever.
